Cargando…
Identification of Potent Chemotypes Targeting Leishmania major Using a High-Throughput, Low-Stringency, Computationally Enhanced, Small Molecule Screen
Patients with clinical manifestations of leishmaniasis, including cutaneous leishmaniasis, have limited treatment options, and existing therapies frequently have significant untoward liabilities. Rapid expansion in the diversity of available cutaneous leishmanicidal chemotypes is the initial step in...
Autores principales: | Sharlow, Elizabeth R., Close, David, Shun, Tongying, Leimgruber, Stephanie, Reed, Robyn, Mustata, Gabriela, Wipf, Peter, Johnson, Jacob, O'Neil, Michael, Grögl, Max, Magill, Alan J., Lazo, John S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765639/ https://www.ncbi.nlm.nih.gov/pubmed/19888337 http://dx.doi.org/10.1371/journal.pntd.0000540 |
Ejemplares similares
-
Discovery of Diverse Small Molecule Chemotypes with Cell-Based PKD1 Inhibitory Activity
por: Sharlow, Elizabeth R., et al.
Publicado: (2011) -
A Target-Based High Throughput Screen Yields Trypanosoma brucei Hexokinase Small Molecule Inhibitors with Antiparasitic Activity
por: Sharlow, Elizabeth R., et al.
Publicado: (2010) -
Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility
por: LaValle, Courtney R, et al.
Publicado: (2010) -
Investigation of Human Cancers for Retrovirus by Low-Stringency Target Enrichment and High-Throughput Sequencing
por: Vinner, Lasse, et al.
Publicado: (2015) -
Design, Synthesis, and Biological Evaluation of PKD Inhibitors
por: George, Kara M., et al.
Publicado: (2011)